EMILY BREWER: Open Payments
NPI 1841455060 · CHATTANOOGA, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$954 in 50 payments from 16 companies in 2025. Trend: 2023 $895 · 2024 $974 · 2025 $954
Food & beverage: $954
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 15 | $271 |
| Janssen Biotech, Inc. | 9 | $168 |
| Novartis Pharmaceuticals Corporation | 4 | $96 |
| Arcutis Biotherapeutics, Inc. | 4 | $72 |
| Biofrontera Inc. | 3 | $61 |
| Amgen Inc. | 2 | $46 |
| PFIZER INC. | 2 | $42 |
| Ortho Dermatologics, a division of Bausch Health US, LLC | 2 | $39 |
| Galderma Laboratories, L.P. | 2 | $32 |
| Incyte Corporation | 1 | $26 |
Products named: TREMFYA, SKYRIZI, COSENTYX, RINVOQ, Zoryve, OTEZLA, CIBINQO, Cabtreo.
Industry payments across TN — which companies pay providers there.
